may result from type II hypersensitivity, as well. Mast cell activa- tion can result from type III hypersensitivity through the binding of circulating immune complexes ...
7PMVNFt*TTVF
November/December 2012
CORE CURRICULUM Virendra N. Sehgal, MD, Section Editor
Pathophysiology of Adverse Cutaneous Drug Reactions—Applied Perceptions: Part II Virendra N. Sehgal, MD; Prashant Verma, MD; Sambit N. Bhattacharya, MD "EWFSTFDVUBOFPVTESVHSFBDUJPOTBSFBHSPVQXJUIDPNNPONPSQIPMPHZ.VDISFTFBSDIIBTCFFOQFSGPSNFEPOTVDISFBDUJPOT CVUUIFJS QBUIPQIZTJPMPHZJTMBSHFMZVOLOPXOɨFBVUIPSTQSPWJEFBDSJUJDBMBQQSBJTBMPGUIFWBSJPVTBTQFDUTPGUIFJSEJBHOPTJTBOEUSFBUNFOU4PNFPG UIFDPNNPOSFBDUJPOQBUUFSOTBSFJODMVEFEXJUIUIFQSJNFPCKFDUJWFPGIJHIMJHIUJOHUIFJSQBUIPQIZTJPMPHZ SKINmed.o